Document:

Exhibit

Exhibit 10.29

Delivery Date: June 6, 2019
Updated Draft: Reflects immaterial changes made on June 11, 2019 Laura Hamill

Re:    Severance and General Release Agreement Dear Laura:
This Severance and General Release Agreement (this “Severance Agreement”), which provides for a Supplemental Release (together with the general release herein, the “Releases,” and this Severance Agreement and the Supplemental Release together shall be referred to as the “Agreement”) confirms your separation of employment with Gilead Sciences, Inc. (the “Company”), as well as the benefits the Company will provide to you in exchange for your consent to be bound by the terms of this Agreement and execution of the Releases under and in accordance with the terms of your letter agreement with the Company dated August 8, 2018 (the “Letter Agreement”), your equity award agreements with the Company (the “Award Agreements”), and the Gilead Sciences, Inc. Severance Plan (the “Plan”). If you agree to the terms of this Agreement, please sign the last page prior to the expiration date set forth below.

Regardless of whether or not you accept this Agreement, you will receive all earned but unpaid compensation in your final paycheck. In addition, per the terms of the Letter Agreement, you will receive a lump sum cash payment of the final installment of your sign-on bonus in the gross amount of $1,500,000, less applicable withholdings and standard deductions, which will be paid within the thirty (30)-day period following the Separation Date (as defined below) and will be included on an applicable W-2 Form issued by the Company.

SEVERANCE AND GENERAL RELEASE AGREEMENT
In exchange for the terms, conditions and releases set forth below, you and the Company agree as follows:

1.Employment Separation. Your employment relationship with the Company will terminate effective July 1, 2019 (your “Separation Date”). After the Separation Date, you will not perform any further job duties for the Company or render services to the Company in any other capacity. For the avoidance of doubt, your termination of employment is a termination by the Company without “Cause,” including for purposes of the Letter Agreement and the Award Agreements.

    

	
					
	Laura Hamill
	 
	 
	 
	Page 2 of 13

2.Severance Pay Benefits. If you (i) sign, timely deliver, and do not revoke this Severance Agreement as described in Paragraph 21 and (ii) sign and timely deliver the Supplemental Release in the form set forth as Attachment A hereto (the “Supplemental Release”) on the Separation Date and do not subsequently revoke the Supplemental Release within the time period set forth therein, the Company will, following the Effective Date (as defined in the Supplemental Release), provide you with the following benefits (collectively, the “Severance Pay Benefit”), subject to the terms and conditions contained in this Agreement, the Award Agreements, and the Plan:

(a)    Cash payments in the total gross amount of $1,447,500, less all applicable withholdings and standard deductions (the “Severance Payment”). The Severance Payment represents the equivalent of eighteen (18) months of your current base salary. The Severance Payment will be paid in a series of successive equal periodic installments over eighteen months. The first such installment will be paid, in accordance with the Plan, within the sixty (60)-day period following the Effective Date. Each subsequent installment will be paid on a successive basis thereafter on each regularly-scheduled pay date for the Company’s salaried employees. The Severance Payment amount will be included on applicable W-2 Forms issued by the Company.

(b)    A lump sum cash payment in the gross amount of $1,7500,000, less all applicable withholdings and standard deductions (the “Lump Sum Incentive Payment”), which reflects your forfeiture of a 2019 annual bonus opportunity, ineligibility to receive a bonus-based payment under the Severance Plan, and forfeiture of 2019 equity awards. The Lump Sum Incentive Payment will be paid within the sixty (60)-day period following the Effective Date. The Lump Sum Incentive Payment will be included on an applicable W-2 Form issued by the Company.

(c)    A lump sum cash payment in the gross amount of $45,076.86, less all applicable withholdings and standard deductions, which is intended to partially offset costs of your health care continuation coverage as if you were electing coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (COBRA) for eighteen (18) months (the “Lump Sum Health Care Payment”). Please note that if you are not a participant in the Company’s group health care plan as of your Separation Date, you will not be eligible for the Lump Sum Health Care Payment. The Lump Sum Health Care Payment, if applicable, will be paid within the sixty (60)-day period following the Effective Date. The Lump Sum Health Care Payment amount will be included on an applicable W-2 Form issued by the Company.

(d)    A lump sum cash payment in the gross amount of $10,000, less all applicable withholdings and standard deductions, which is intended to partially offset costs of professional outplacement services (the “Lump Sum Outplacement Services Payment”). The Lump Sum Outplacement Services Payment is paid in lieu of and in satisfaction of the outplacement services provided for under the Plan and will paid within the sixty (60)-day period following the Effective Date. The Lump Sum Outplacement Services Payment amount will be included on an applicable W-2 Form issued by the Company.

	
					
	Laura Hamill
	 
	 
	 
	Page 3 of 13

(e)    Accelerated vesting, as of the Separation Date, of the 87,680 unvested stock options subject to your October 7, 2018 grant of stock options per the terms of the Letter Agreement and the applicable Award Agreement. In addition, notwithstanding the terms of the Award Agreement applicable to such stock options, such vested options shall remain exercisable for a period of twelve (12) months following the Separation Date.

(f)    Accelerated vesting, as of the Separation Date, of the 32,795 shares subject to your October 7, 2018 grant of time-based restricted stock units per the terms of the applicable Award Agreement.

(g)    Accelerated vesting, as of the Separation Date, of the 42,630 shares subject to your October 7, 2018 grant of performance-based restricted stock units, without regard to your level of attainment of applicable performance objectives, per the terms of the applicable Award Agreement.

(h)    Reimbursement or direct payment of your reasonable relocation expenses to return to southern California, including movement of your household goods and fees to break your automobile lease as well as any expenses that may be assessed against you in connection with the northern California house lease that was maintained for you by the Company. Such payments will be subject to any applicable withholdings and deductions.

(i)    Your Severance Payment and Lump Sum Health Care Payment are subject to reduction as authorized under the Plan, including but not limited as per Section IV(b)(ii) of the Plan. Similarly, your eligibility to receive a Severance Pay Benefit is subject to disqualification as authorized under the Plan, including but not limited as per Section IV(a) of the Plan. In the event you are receiving short- term sick leave benefits on your Separation Date, then (1) as a condition of receiving the Severance Payment and Lump Sum Health Care Payment, you must execute and deliver to the Company within thirty (30) days of your Separation Date a written waiver of any short-term sick leave benefits that might otherwise be payable after termination of your employment with the Company, as required under Section IV(a)(ii)(3) of the Plan, and
(2) notwithstanding anything to the contrary set forth in this Agreement, your Severance Payment and Lump Sum Health Care Payment will not be provided unless and until you timely deliver the written waiver and the thirty (30) day maximum waiver delivery period has expired.

(j)    Notwithstanding any provision to the contrary, no Severance Pay Benefit (or component thereof) that is deemed to constitute “nonqualified deferred compensation” within the meaning of and subject to Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”) shall commence until the earlier of (i) the first day of the seventh (7th) month following the Separation Date or (ii) the date of your death, if you are deemed at the Separation Date to be a Specified Employee and such delayed commencement is otherwise required in order to avoid a prohibited distribution under Code Section 409A(a)(2). Upon the expiration of the applicable deferral period, all payments deferred pursuant to this Paragraph 2(j), whether they were otherwise payable in installments or a lump sum, shall be paid to you in a lump sum, and

	
					
	Laura Hamill
	 
	 
	 
	Page 4 of 13

any remaining Severance Pay Benefit shall be paid in accordance with the schedule described above.

3.Repayment Obligations. Without regard to the Lump Sum Incentive Payment, in the event you receive other payments under this Severance Agreement in excess of the Severance Pay Benefit to which you are entitled under the Letter Agreement, the Plan and the Award Agreements, including in consideration for authorized reductions and/or eligibility disqualifications under the Plan, you agree to repay the applicable excess amounts to the Company if requested to do so by the Company within sixty (60) days following your notifying the Company of your receipt of the excess amounts.

4.Cessation of Company Benefits. Except as expressly provided otherwise herein, your eligibility to participate in the Company’s employee benefit plans and programs, such as the Company’s 401K plan, short and long term disability insurance, life insurance, vesting in stock options, performance shares or restricted stock unit awards, the employee stock purchase plan, and vacation vesting, is governed by the terms of applicable award agreements, benefits plans and programs, and will cease in accordance with those terms. If you participate in the Company’s group health insurance, your health insurance benefits will cease on the last day of the month in which your Separation Date falls, subject to your right to continue health insurance for you and any eligible dependents under COBRA or other applicable law should you be eligible to and make a timely election to do so. All of your other benefits will end on your Separation Date.

5.Entire Consideration. You agree and acknowledge that the Severance Pay Benefit constitutes benefits that you would not otherwise be entitled to receive, now or in the future, and constitutes valuable consideration for the promises set forth in this Agreement. You agree that the Severance Pay Benefit will constitute the entire amount of monetary consideration provided to you under this Agreement, that you do not have any unused vacation time for which you are entitled to payment, and that you will not seek from the Company or the Releasees (as defined below) any further compensation or other consideration for any other claimed obligation, entitlement, damage, cost, or attorneys’ fees in connection with the matters encompassed by this Agreement.

6.Release of Claims. The Company represents that as of the date hereof, the Company is not aware of any claims that it has against you. In consideration of the promises and commitments undertaken herein by the Company, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, you release, discharge, and covenant not to sue the Company, including its parents, subsidiaries, affiliates, partners, trustees, members, owners, labor contractors, staffing agencies, and related companies, and all of its and their respective past and present employees, directors, officers, shareholders, attorneys, representatives, insurers, agents, successors, predecessors and assignees, (individually and collectively the “Releasees”) with respect to any and all actions, causes of action, suits, liabilities, claims, and demands whatsoever (upon any legal or equitable theory, whether contractual, in tort, common law, statutory, federal, state, local or otherwise), and each of them,

    

	
					
	Laura Hamill
	 
	 
	 
	Page 5 of 13

whether known or unknown, from the beginning of time up to and including the date you sign this Severance Agreement. The parties intend this release to be general and comprehensive in nature and to release all claims and potential claims against the Releasees to the maximum extent permitted at law. Claims being released include specifically by way of description, but not by way of limitation, any and all claims:

(a)    arising out of or in any way related to your employment with the Company or any Releasee, including without limitation claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1866 and 1871, the Civil Rights Act of 1991, the Pregnancy Discrimination Act, the Equal Pay Act of 1973, the Rehabilitation Act of 1973, 42 U.S.C. § 1981, the Americans with Disabilities Act, the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act of 1990, the Equal Pay Act of 1963, the California Fair Employment and Housing Act, the Pregnancy Disability Leave law, the Family and Medical Leave Act, the California Family Rights Act, the Healthy Workplace Healthy Family Act of 2014, the Employee Retirement Income Security Act, as amended, the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, the Occupational Safety and Health Act, the Immigration Reform and Control Act, the Worker Adjustment and Retraining Notification Act of 1988, the Health Insurance Portability and Accountability Act of 1996, the National Labor Relations Act of 1935, the Fair Labor Standards Act, the California Labor Code, the Private Attorneys’ General Act (Labor Code§ 2698 et seq.), any Wage Orders issued by the California Industrial Welfare Commission, the California Business and Professionals Code, and any similar laws or regulations of any state, local, or federal governmental entity;

(b)    arising out of or in any way related to any federal, state, or local law prohibiting bullying, harassment, retaliation, wrongful termination, or discrimination on any basis, including on the basis of age, sex, gender, race, color, religion, disability, medical condition, genetic information, pregnancy, sexual orientation, national origin, marital status, military or veteran status, citizenship, or for exercising any legal rights or otherwise engaging in any protected or concerted activity;

(c)    for breach of contract (express or implied), breach of promise, wrongful discharge, unjust dismissal, retaliation, whistleblowing, breach of fiduciary duty, breach of implied covenant of good faith and fair dealing, defamation, wrongful denial of benefits, intentional and negligent infliction of emotional distress, negligence, and any intentional torts;

(d)    for any alleged unpaid wages due, as to which you have considered and agree that there is a good-faith dispute as to whether such wages are due, and, based on this good-faith dispute, you release and waive any and all claims regarding any alleged unpaid wages and any corresponding penalties, interest, or attorneys’ fees, in exchange for the consideration provided in this Agreement; and

    

	
					
	Laura Hamill
	 
	 
	 
	Page 6 of 13

(e)    for any remedies available at law or in equity, including damages, penalties, restitution, liens, injunctive relief, or the recovery of attorneys’ fees, costs, or expert witness fees.

The only claims that you are not releasing under this Severance Agreement are (i) claims for payment under this Severance Agreement, (ii) claims for vested benefits (including rights under equity awards), (iii) rights to coverage under indemnification agreements or policies or directors and officers liability insurance and (iv) claims you may have for violation of any federal, state or local law that, by operation of law, are not waivable, including but not limited to unemployment, state disability, and California Labor Code Section 2802. With regard to Labor Code Section 2802 or similar law of any other state, you represent and warrant that you have been reimbursed all business expenses and other expenditures incurred in direct consequence of your duties for the Company.

This release of claims does not prevent you or the Company or any Releasee from seeking a binding determination as to the validity of this Agreement or bringing an action in arbitration to enforce this Agreement.

7.Waiver of Unknown Claims. You expressly waive any and all rights or benefits conferred by the provisions of Section 1542 of the California Civil Code or similar law of any other state, and consent that this Severance Agreement shall be given full force and effect according to each and all of its express terms and conditions, including those relating to unknown and unsuspected claims, demands and causes of actions, if any. Section 1542 of the Civil Code states:

“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release, and that if known by him or her, would have materially affected his or her settlement with the debtor or released party.”
You acknowledge that you may later discover claims or facts in addition to or different to those which you now know or believe to exist with respect to the subject matter of this Agreement and which, if known or suspected at the time of executing this Severance Agreement, may have materially affected this settlement. Nevertheless, you waive any right, claim or cause of action that might arise as a result of such different or additional claims or facts.

8.Covenant Not to Sue. As to any claim released under the Releases, you specifically agree and acknowledge that: (a) such claims, including those you have or might have pertaining to your employment with any Releasee, or separation of employment from any Releasee, or pertaining to any Releasee’s employment practices arising under any municipal, state, or federal law, are completely released; and (b) you have not filed or initiated any pending complaints, charges, claims, or causes of action against any Releasee with any municipal, state, or federal government agency or court directly or indirectly related to your employment with Company. You agree not to reargue, reinstitute, refile, appeal, renew, or seek reconsideration or any kind of judicial review of any of the claims released under this Agreement in any court or

    

	
					
	Laura Hamill
	 
	 
	 
	Page 7 of 13

other legal forum whatsoever, nor shall any other court actions, suits, appeals or other legal proceedings of any type be pursued or filed that are connected in any fashion to your employment with the Company or to your separation from employment. For the sake of clarity, this covenant not to sue does not prevent you from seeking a binding determination as to the validity of this Agreement or from engaging in any protected activity described in Paragraph 9, nor does it cover any claim not released under the Releases.

9.Protected Activity. Nothing in this Agreement shall be construed to prohibit you from engaging in any protected or concerted activity, or filing a complaint or charge with, or participating in any investigation or proceeding conducted by, or providing information to or otherwise assisting the Equal Opportunity Employment Commission, Department of Fair Employment and Housing, National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state, or local governmental agency or commission (“Government Agencies”). By signing this Agreement you agree to waive your right to recover individual relief based on any claims asserted in such a complaint or charge; provided, however, that nothing in this Agreement limits your right to receive an award for information you provide to any Government Agencies that are authorized to provide monetary or other awards to eligible individuals who come forward with information that leads to an agency enforcement action. You further understand that this Agreement does not limit your ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any of the Government Agencies, including providing documents or other information, without notice to the Company.  Should any charge or action be filed on your behalf involving claims released by the Releases, you agree to promptly inform the relevant agency, court, or arbitral forum that any individual claims you might otherwise have had have been released.

10.No Admission of Liability. Neither this Agreement, nor anything contained in it, shall constitute or shall be used or construed as an admission or as evidence of any liability or wrongdoing. Neither this Agreement, nor anything contained in it, shall be introduced in any proceeding except to enforce this Agreement or to defend against any claim relating to the subject matter of the release contained herein or as required by court order, subpoena or other legal process, and such introduction under these exceptions shall be pursuant to an appropriate order protecting its confidentiality.

11.Confidentiality. You will not, without compulsion of legal process, disclose to others, either directly, indirectly or by implication, the amounts referred to in this Agreement (either by specific dollar amount, by number of “figures”, or otherwise), or the fact of the payment of said amounts, except that you may disclose such information to your spouse, accountants, attorneys or other professional advisors to effect the purposes for which they have been consulted, where disclosure is required by law or where disclosure constitutes protected activity described in Paragraph 9. You specifically agree that your obligation to maintain the confidentiality of this Agreement is a material term of this Agreement.

    

	
					
	Laura Hamill
	 
	 
	 
	Page 8 of 13

12.Non-Solicitation of Employees. You agree not to interfere with the Company’s business by soliciting, or causing or encouraging another person to solicit, any employee of the Company to terminate or cease his or her employment with the Company for a period from the Separation Date through twelve (12) months after either your Separation Date or the Effective Date of the Supplemental Release, whichever is later.

13.Governing Law and Venue. The rights and obligations of you and the Company will be construed and enforced in accordance with, and will be governed by, the laws of the State of California, without regard to principles of conflict of laws.  Any dispute or claim arising out of or in connection with this Agreement or relating in any way to your employment, including any dispute regarding the enforceability, interpretation, construction or breach of this Agreement, will be resolved exclusively by binding arbitration in accordance with the then-applicable JAMS rules, policies, and/or procedures for employment-related disputes provided, however, that any claims, which by law may not be submitted to arbitration are not covered by this arbitration provision. This means that both you and the Company give up the right to have any dispute decided in court by a jury; instead, a neutral arbitrator whose decision is final and binding will resolve it, subject to judicial review as provided by law. Furthermore, any such dispute or claim shall be brought in an individual capacity, and not as a plaintiff or class member in any purported or actual class or collective action proceeding except where applicable law prohibits a class or collective action waiver.  A copy of the JAMS Employment Arbitration Rules and Procedures can be found online at www.jamsadr.com/rules-employment-arbitration/. There will be one arbitrator appointed in accordance with said rules. The arbitrator will conduct any arbitration consistent with the rules. The arbitrator will have the authority to determine the arbitrability of any dispute between the parties. The arbitrator will have the authority to award attorneys’ fees to the prevailing party pursuant to statute or this Agreement as described below in Paragraph 24. If there is a dispute as to who is the prevailing party in the arbitration, the arbitrator will decide this issue.

14.Confidentiality Agreement. You acknowledge that you signed an Employee Confidential Information and Invention Assignment Agreement (“CIIA”) in connection with your employment with the Company, and that your obligations to protect the Company’s confidential and proprietary information, and prevent the disclosure of any such information in your possession, are continuing and survive the termination of your employment with the Company. You understand that the Company may not hold you criminally or civilly liable under any Federal or State trade secret law or any agreement for the disclosure of a trade secret that is made: (a) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, provided that such disclosure is solely for the purpose of reporting or investigating a suspected violation of law, or (b) in a complaint or other document filed in a lawsuit or other proceeding, provided that such filing is made under seal.

15.Neutral Reference. The Company agrees that if it is asked for a reference, it will respond that pursuant to Company policy, the Company can only provide your name, your position, the dates of your employment and, with written authorization from you, your salary and

    

	
					
	Laura Hamill
	 
	 
	 
	Page 9 of 13

will provide only such information in response to a request for a reference. Such inquiries should be directed to HR Answer at 650-522-5511 or e-mail HR.Answer@gilead.com.

16.Cooperation.  You agree to provide reasonable information when requested by the Company about subjects you worked on during your employment. You further agree to cooperate fully with the Company to facilitate an orderly transition of your job responsibilities to person(s) designated by the Company, and in connection with any claim, investigation or litigation in which the Company deems that your cooperation is needed. Nothing in this Agreement shall require you to act in an unlawful manner. You agree that the Severance Pay Benefit you receive pursuant to this Agreement is intended to fully compensate you for any services you perform pursuant to this Paragraph, and will be in lieu of any fee or other compensation you might otherwise receive for your services.

17.Non-Disparagement; No Cooperation. Other than in connection with filing a charge or participating in any investigation or proceeding conducted by the Equal Employment Opportunity Commission, the National Labor Relations Board, or other comparable federal, state, or local governmental agency or commission, under a valid subpoena or court order to do so, or when constituting protected activity described in Paragraph 9, you will not criticize, denigrate, or otherwise disparage the Company, or any other Releasee, or any of their products, processes, policies, practices, standards of business conduct, or areas of research, or counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against the Company or any Releasee. The Company agrees to instruct its Chief Executive Officer, Daniel O’Day, not to criticize, denigrate, or otherwise disparage you.

18.Integration and Amendment. This Agreement, including the Releases, the Award Agreements and the Plans, collectively, constitute and contain the entire agreement and understanding between the parties concerning the subject matters specifically addressed herein, including but not limited to eligibility for and payment of severance or separation benefits, and supersedes and replaces all prior negotiations and all agreements proposed or otherwise, whether written or oral. This Agreement, however, does not modify, amend or supersede written Company agreements that are consistent with enforceable provisions of this Agreement, and any other agreements regarding intellectual property, invention assignment and confidentiality, including but not limited to any confidentiality agreements previously signed by you. Any CIIA is herein incorporated by reference and remain fully enforceable as part of this integrated document. Except for any changes that the Company may make with respect to Section 409A as set forth in Paragraph 23 of this Severance Agreement, this Agreement can only be changed or modified by another written agreement signed by you and the Company’s Executive Vice President, Human Resources.

19.Severability. If any provision of this Agreement or the application thereof is held invalid, such invalidation will not affect other provisions or applications of this Agreement and to this end, the provisions of this Agreement are declared to be severable.

    

	
					
	Laura Hamill
	 
	 
	 
	Page 10 of 13

20.Execution and Copies. This Agreement may be executed in counterparts, and each counterpart, when executed, shall have the efficacy of a signed original. Photographic, PDF, and facsimiled copies of signed counterparts may be used in lieu of the originals for any purpose.

21.Knowing and Voluntary Agreement. You expressly recognize and agree that, by entering into this Agreement, you are waiving any and all rights or claims that you may have arising under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act of 1990, which have arisen on or before the date you execute this Agreement. By your signature below, you understand and agree that:

(a)    To accept this Severance Agreement, you must sign, date, and return this Severance Agreement to the Company’s Executive Vice President of Human Resources at the address set forth below by 5:00 p.m. on June 27, 2019, which is at least twenty-one (21) full calendar days from the Delivery Date.  You have twenty-one (21) full calendar days within which to consider this Severance Agreement before executing it. You are free to sign this Severance Agreement in less than 21 days if you wish but you understand that if you take fewer than 21 days to review and sign this Severance Agreement, you knowingly and voluntarily waive your right to review for the full 21-day period. Once you have accepted, signed, and dated, this Severance Agreement, please return it to the Company’s Executive Vice President of Human Resources at the address below:

Katie Watson
Executive Vice President, Human Resources Gilead Sciences, Inc.
333 Lakeside Drive Foster City, CA 94404
Katie.Watson@gilead.com

(b)    Unless more time is required by applicable law or as set forth below, you have seven (7) calendar days within which to revoke this Severance Agreement after it is executed by you (the "Revocation Period"). Any such revocation shall be in writing and shall be sent by certified mail to:

Katie Watson
Executive Vice President, Human Resources Gilead Sciences, Inc.
333 Lakeside Drive Foster City, CA 94404
Your written revocation must be postmarked on or before the end of the seventh (7th) day after you initially signed the Agreement, provided, however, that the expiration of the Revocation Period and deadline to submit your written revocation will be extended to the next business day

    

	
					
	Laura Hamill
	 
	 
	 
	Page 11 of 13

after such Revocation Period expires should the 7th day fall on a Saturday, Sunday, or holiday recognized by the U.S. Postal Service, or if a revocation period longer than seven (7) calendar days is required under applicable law. If you revoke this Severance Agreement and/or the Supplemental Release, your employment termination as of the Separation Date will remain in effect; however, you will not be entitled to the Severance Pay Benefit offered in this Agreement.

(c)    You have carefully read and fully understand all of the provisions of this Agreement and are hereby advised to consult with legal counsel.

(d)    You are, through this Agreement, releasing the Company from any and all claims you may have against the Company consistent with the terms of this Agreement; provided, however, that you understand that rights or claims that may arise after the date of signing are not waived.

(e)    You knowingly and voluntarily agree to all of the terms set forth in this Severance Agreement.

(f)    You knowingly and voluntarily intend to be legally bound by the terms set forth in this Agreement.

(g)    If you revoke either of the Releases, the provisions of Paragraph 2 of this Severance Agreement shall not be effective or enforceable. Regardless of whether you revoke the Releases in the time periods specified therein, the Severance Agreement as it relates to all matters other than the Releases shall become effective on the date you sign it.

22.Return of Property. On or before the Separation Date, and as a condition precedent to your receipt of the Severance Pay Benefit, you will return to the Company any and all Company property, including, but not limited to, documents (in whatever paper or electronic form they exist), things relating to the business of the Company or containing confidential information and all intellectual, electronic and physical property belonging to the Company that is in your possession or control, including but not limited to any Company computer, laptop, cell phone, tablet, office keys, credit card, entry cards, and identification badges.

23.Deferred Compensation Tax Consequences. All payments and benefits described in this Agreement are intended to comply with the requirements of Section 409A or an exemption therefrom; provided, however, that the Company does not warrant or guarantee such compliance. Under no circumstances may the time or schedule of any payment made or benefit provided pursuant to this Agreement be accelerated or subject to a further deferral except as permitted or required pursuant to regulations and other guidance issued pursuant to Section 409A. You shall not have any right to make any election regarding the time or form of any payment due under the terms of this Agreement. In the event that any change to this Agreement or any additional terms are required to comply with Section 409A (or an exemption therefrom), the parties shall cooperate and use reasonable efforts to modify the terms of this Agreement to comply with Section 409A while preserving the economic benefits hereunder to the extent possible. Furthermore, neither the Company nor its counsel has made any representations

    

	
					
	Laura Hamill
	 
	 
	 
	Page 12 of 13

regarding the taxability of the monetary consideration to be made by the Company pursuant to this Agreement. You understand and expressly agree that in the event any income or other taxes, including any interest and/or penalties, are determined to be owed by you on any portion of the payments made hereunder, you are solely responsible for the payment of such amounts, and you agree that you shall fully indemnify the Company for any taxes, penalties, interests, fees, costs and other damages incurred or paid by the Company related to the taxability of the payments made hereunder. Company agrees to notify you within a reasonable time period regarding any payments sought from it for such alleged taxes, penalties, interest, fees, costs and/or other damages related to the taxability of payments made by it pursuant to this Agreement so that you will have a reasonable opportunity to defend against such claims.

24.Attorneys’ Fees and Costs. In the event that either the Company or you bring an action to enforce this Agreement, the prevailing party shall be entitled to recover its costs and expenses, including the cost of arbitration and all reasonable attorneys’ fees incurred in connection with such an action.

    

	
					
	Laura Hamill
	 
	 
	 
	Page 13 of 13

To accept these terms, please sign and date below and return this Agreement as set forth above. The offer of this Agreement shall expire at 5:00 p.m. on June 27, 2019, which is at least the twenty-first (21st) calendar day after the Delivery Date.

Sincerely,

/s/ Katie Watson
Name: Katie Watson
Title: EVP, Human Resources

PLEASE READ CAREFULLY. THIS AGREEMENT CONTAINS A GENERAL RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.
I have read and understood the foregoing Severance and General Release Agreement, have been advised to and have had the opportunity to discuss it with anyone I desire, including an attorney of my own choice, and I accept and agree to its terms, acknowledge receipt of a copy of the same and the sufficiency of the Severance Pay Benefit described above, and hereby execute this Severance and General Release Agreement voluntarily and with full understanding of its consequences.

/s/ Laura Hamill
Laura Hamill    Date

    

Attachment A

PLEASE READ CAREFULLY. THIS AGREEMENT CONTAINS A GENERAL RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS.
SUPPLEMENTAL RELEASE OF CLAIMS

This Supplemental Release (this “Supplemental Release”), is made between Laura Hamill (“Hamill”) and Gilead Sciences, Inc. (“Gilead”) pursuant to the Severance and General Release Agreement by and between Hamill and Gilead (the “Severance Agreement”), and is effective on the Effective Date set forth in Paragraph 2 of this Supplemental Release.

		
	1.
	Hamill’s Release of Claims.

(a)    General Release. In consideration of the promises and commitments undertaken by Gilead in the Severance Agreement, and for other good and valuable consideration, the receipt and sufficiency of which Hamill hereby acknowledges, Hamill hereby releases, discharges, and covenants not to sue Gilead, including its parents, subsidiaries, affiliates, partners, trustees, members, owners, labor contractors, staffing agencies, and related companies, and all of its and their respective past and present employees, directors, officers, shareholders, attorneys, representatives, insurers, agents, successors, predecessors and assignees, (individually and collectively the “Releasees”) with respect to any and all actions, causes of action, suits, liabilities, claims, and demands whatsoever (upon any legal or equitable theory, whether contractual, in tort, common law, statutory, federal, state, local or otherwise), and each of them, whether known or unknown, from the beginning of time up to and including the date Hamill executes this Supplemental Release. Hamill and Gilead intend this release to be general and comprehensive in nature and to release all claims and potential claims against the Releasees to the maximum extent permitted at law. Claims being released include specifically by way of description, but not by way of limitation, any and all claims:

(i)    arising out of or in any way related to Hamill’s employment with Gilead or any Releasee, including without limitation claims under Title VII of the Civil Rights Act of 1964, as amended, the Civil Rights Act of 1866 and 1871, the Civil Rights Act of 1991, the Pregnancy Discrimination Act, the Equal Pay Act of 1973, the Rehabilitation Act of 1973, 42
U.S.C. § 1981, the Americans with Disabilities Act, the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act of 1990, the Equal Pay Act of 1963, the California Fair Employment and Housing Act, the Pregnancy Disability Leave law, the Family and Medical Leave Act, the California Family Rights Act, the Healthy Workplace Healthy Family Act of 2014, the Employee Retirement Income Security Act, as amended, the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, the Occupational Safety and Health Act, the Immigration Reform and Control Act, the Worker Adjustment and Retraining Notification Act of 1988, the Health Insurance Portability and Accountability Act of 1996, the National Labor Relations Act of 1935, the Fair Labor Standards Act, the California Labor Code, the Private Attorneys’ General Act (Labor Code§ 2698 et seq.), any Wage Orders issued by the California Industrial Welfare Commission, the California Business and

A-1

    

Professionals Code, and any similar laws or regulations of any state, local, or federal governmental entity;

(ii)    arising out of or in any way related to any federal, state, or local law prohibiting bullying, harassment, retaliation, wrongful termination, or discrimination on any basis, including on the basis of age, sex, gender, race, color, religion, disability, medical condition, genetic information, pregnancy, sexual orientation, national origin, marital status, military or veteran status, citizenship, or for exercising any legal rights or otherwise engaging in any protected or concerted activity;

(iii)    for breach of contract (express or implied), breach of promise, wrongful discharge, unjust dismissal, retaliation, whistleblowing, breach of fiduciary duty, breach of implied covenant of good faith and fair dealing, defamation, wrongful denial of benefits, intentional and negligent infliction of emotional distress, negligence, and any intentional torts;

(iv)    for any alleged unpaid wages due, as to which Hamill has considered and agree that there is a good-faith dispute as to whether such wages are due, and, based on this good-faith dispute, Hamill releases and waives any and all claims regarding any alleged unpaid wages and any corresponding penalties, interest, or attorneys’ fees, in exchange for the consideration provided in the Severance Agreement; and

(v)    for any remedies available at law or in equity, including damages, penalties, restitution, liens, injunctive relief, or the recovery of attorneys’ fees, costs, or expert witness fees.

The only claims that Hamill is not releasing under this Supplemental Release are (i) claims for payment under the Severance Agreement, (ii) claims for vested benefits (including rights under equity awards), (iii) rights to coverage under indemnification agreements or policies or directors and officers liability insurance and (iv) claims Hamill may have for violation of any federal, state or local law that, by operation of law, are not waivable, including but not limited to unemployment, state disability, and California Labor Code Section 2802. With regard to Labor Code Section 2802 or similar law of any other state, Hamill represents and warrants that Hamill has been reimbursed all business expenses and other expenditures incurred in direct consequence of Hamill’s duties for Gilead.

This Supplemental Release does not prevent Hamill or Gilead or any Releasee from seeking a binding determination as to the validity of this Supplemental Release or the Severance Agreement or bringing an action in arbitration to enforce this Supplemental Release or the Severance Agreement.

(b)    Waiver of Unknown Claims. Hamill expressly waives any and all rights or benefits conferred by the provisions of Section 1542 of the California Civil Code or similar law of any other state, and consents that this Supplemental Release and the Severance Agreement shall be given full force and effect according to each and all of its express terms and conditions, including those relating to unknown and unsuspected claims, demands and causes of actions, if any. Section 1542 of the Civil Code states:

A-2

    

“A general release does not extend to claims that the creditor or releasing party does not know or suspect to exist in his or her favor at the time of executing the release, and that if known by him or her, would have materially affected his or her settlement with the debtor or released party.”
Hamill acknowledges that Hamill may later discover claims or facts in addition to or different to those which Hamill now knows or believes to exist with respect to the subject matter of this Supplemental Release and the Severance Agreement and which, if known or suspected at the time of executing this Supplemental Release, may have materially affected this settlement.
Nevertheless, Hamill waives any right, claim or cause of action that might arise as a result of such different or additional claims or facts.

(c)    Covenant Not to Sue. As to any claim released under the Releases, Hamill specifically agrees and acknowledges that: (a) such claims, including those Hamill has or might have pertaining to Hamill’s employment with any Releasee, or separation of employment from any Releasee, or pertaining to any Releasee’s employment practices arising under any municipal, state, or federal law, are completely released; and (b) Hamill has not filed or initiated any pending complaints, charges, claims, or causes of action against any Releasee with any municipal, state, or federal government agency or court directly or indirectly related to Hamill’s employment with Gilead. Hamill agrees not to reargue, reinstitute, refile, appeal, renew, or seek reconsideration or any kind of judicial review of any of the claims released under this Agreement in any court or other legal forum whatsoever, nor shall any other court actions, suits, appeals or other legal proceedings of any type be pursued or filed that are connected in any fashion to Hamill’s employment with Gilead or to Hamill’s separation from employment. For the sake of clarity, this covenant not to sue does not prevent Hamill from seeking a binding determination as to the validity of this Supplemental Release or from engaging in any protected activity described in Paragraph 1(d), nor does it cover any claim not released under this Supplemental Release.

(d)    Protected Activity. Nothing in this Agreement shall be construed to prohibit Hamill from engaging in any protected or concerted activity, or filing a complaint or charge with, or participating in any investigation or proceeding conducted by, or providing information to or otherwise assisting the Equal Opportunity Employment Commission, Department of Fair Employment and Housing, National Labor Relations Board, the Occupational Safety and Health Administration, the Securities and Exchange Commission or any other federal, state, or local governmental agency or commission (“Government Agencies”). By signing this Agreement Hamill agrees to waive Hamill’s right to recover individual relief based on any claims asserted in such a complaint or charge; provided, however, that nothing in this Agreement limits Hamill’s right to receive an award for information Hamill provide to any Government Agencies that are authorized to provide monetary or other awards to eligible individuals who come forward with information that leads to an agency enforcement action. Hamill further understands that this Agreement does not limit Hamill’s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any of the Government Agencies, including providing documents or other information, without notice to Gilead. Should any charge or action be filed on Hamill’s behalf involving claims released by the Releases, Hamill agrees to promptly inform the relevant agency, court, or arbitral forum that any individual claims Hamill might otherwise have had have been released.

A-3

    

(e)    Knowing and Voluntary Agreement. Hamill expressly recognizes and agrees that, by entering into this Agreement, Hamill is waiving any and all rights or claims that Hamill may have arising under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act of 1990, which have arisen on or before the date Hamill executes this Agreement.

		
	2.
	Revocation and Effective Date.

(a)    Hamill acknowledges that Hamill has carefully read and fully understands all of the provisions of this Supplemental Release and is hereby advised to consult with legal counsel. Hamill acknowledges that Hamill has twenty-one (21) full calendar days within which to consider this Supplemental Release before executing it. Hamill is free to sign this Supplemental Release in less than 21 day, but should Hamill take fewer than 21 days to review and sign this Supplemental Release, Hamill knowingly and voluntarily waives Hamill’s right to review for the full 21-day period. Hamill further acknowledges that unless more time is required by applicable law or as set forth below, Hamill has seven (7) calendar days within which to revoke this Supplemental Release after it is executed by Hamill (the "Revocation Period"). Any such revocation shall be in writing and shall be sent by certified mail to:

Katie Watson
Executive Vice President, Human Resources Gilead Sciences, Inc.
333 Lakeside Drive Foster City, CA 94404
Hamill’s written revocation must be postmarked on or before the end of the seventh (7th) day after Hamill initially signed the Supplemental Release, provided, however, that the expiration of the Revocation Period and deadline to submit the written revocation will be extended to the next business day after such Revocation Period expires should the 7th day fall on a Saturday, Sunday, or holiday recognized by the U.S. Postal Service, or if a revocation period longer than seven (7) calendar days is required under applicable law. If Hamill revoke this Supplemental Release, Hamill will not be entitled to the Severance Pay Benefit (as defined in the Severance Agreement). If Hamill does not revoke this Supplemental Release in the time specified above, the Supplemental Release shall become effective once the Revocation Period expires (the “Effective Date”).

(b)    This Supplemental Release may be executed in counterparts, and each counterpart, when executed, shall have the efficacy of a signed original. Photographic, PDF, and facsimiled copies of signed counterparts may be used in lieu of the originals for any purpose.

(c)    This Supplemental Release was entered into in California and the rights and obligations of Hamill and Gilead will be construed and enforced in accordance with, and will be governed by, the laws of the State of California, without regard to principles of conflict of laws.

A-4

    

Integration.

This Supplemental Release shall constitute a part of the Severance Agreement entered into by and between Gilead and Hamill, which collectively constitute and contain the entire agreement and understanding between the parties concerning the subject matters specifically addressed herein, including but not limited to eligibility for and payment of severance or separation benefits, and supersedes and replaces all prior negotiations and all agreements proposed or otherwise, whether written or oral. Except as otherwise set forth in this Supplemental Release, this Supplemental Release shall be governed by the terms and conditions of the Severance Agreement.

I have read and understood the foregoing Supplemental Release, have been advised to and have had the opportunity to discuss it with anyone I desire, including an attorney of my own choice, and I accept and agree to its terms, acknowledge receipt of a copy of the same and the sufficiency of the monies and benefits described above, and hereby execute this Supplemental Release voluntarily and with full understanding of its consequences.

EXECUTED this     day of     , 2019, at     .

Laura Hamill
EXECUTED this     day of     2019, at Foster City, California. Gilead Sciences, Inc.

		
	By:
	         Katie Watson

Executive Vice President, Human Resources

A-5II_Ex_4_2

		

			 

		

		
			Exhibit 4.02 
		

		
			Description of the Registrant’s Securities Registered
		

		
			Under Section 12 of the Exchange Act of 1934
		

		
			DESCRIPTION OF CAPITAL STOCK 
		

		
			The following summary of the material terms of the capital stock of Lumber Liquidators Holdings, Inc. (“Lumber Liquidators,” “we,” or “our”) does not purport to be complete and is subject to and qualified in its entirety by reference to our certificate of incorporation and bylaws, each of which is incorporated herein by reference and attached as an exhibit to our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission. For a more complete understanding of our capital stock, we encourage you to read carefully our certificate of incorporation and bylaws, each as may be amended, and the applicable provisions of the laws of the state of Delaware.
		

		
			Common Stock 
		

		
			Our authorized capital stock consists of 35,000,000 shares of common stock, with a par value of $0.001 per share and 8,000,000 shares of preferred stock,  with a par value of $0.01 per share. 
		

		
			Holders of common stock will be entitled to one vote for each share held on all matters submitted to a vote of stockholders and do not have cumulative voting rights. Accordingly, holders of a majority of the shares of common stock entitled to vote in any election of directors may elect all of the directors standing for election. In addition, holders of common stock are entitled to receive proportionately any dividends that may be declared by our board of directors, subject to any preferential dividend rights of outstanding preferred stock. Holders of common stock have no preemptive, subscription, redemption or conversion rights. 
		

		
			Upon our liquidation, dissolution or winding-up, the holders of common stock are entitled to receive proportionately our net assets available after the payment of all debts and other liabilities and subject to the prior rights of any outstanding preferred stock. 
		

		
			Our outstanding shares of common stock are validly issued, fully paid and nonassessable. The rights, preferences and privileges of holders of common stock are subject to, and may be impacted by, the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future. 
		

		
			Preferred Stock 
		

		
			Our certificate of incorporation authorizes the issuance of an aggregate of 8,000,000 shares of preferred stock. No shares of preferred stock are currently issued and outstanding. 
		

		
			Our board of directors may, from time to time, direct the issue of shares of preferred stock in series and may, at the time of issue, determine the designation, powers, rights, preferences and limitations of each series. Satisfaction of any dividend preferences of outstanding preferred stock would reduce the amount of funds available for the payment of dividends on shares of common stock. Holders of preferred stock may be entitled to receive a preference payment in the event of any liquidation, dissolution or winding-up of Lumber Liquidators before any payment is made to the holders of common stock. Under certain circumstances, the issuance of preferred stock may render more difficult or tend to discourage a merger, tender offer or proxy contest, the assumption of control by a holder of a large block of securities of Lumber Liquidators or the removal of incumbent management. Upon the affirmative vote of a majority of the total number of directors then in office, the board of directors may issue shares of preferred stock with voting and conversion rights that could adversely affect the holders of shares of common stock. 
		

		
			Preemptive Rights 
		

		
			Our stockholders are not entitled to preemptive rights to subscribe for additional issuances of common stock or any other class or series of common stock or any security convertible into such stock. 
		

		
			Certain Anti-Takeover Effects of our Certificate of Incorporation,  Bylaws and Delaware Law
		

		
			Our certificate of incorporation, bylaws and the Delaware General Corporation Law (“DGCL”) contain provisions that may make it more difficult or expensive for a third party to acquire control of us without the approval of our board of directors. These provisions include a staggered board, the availability of “blank check” preferred stock, provisions restricting stockholders from calling a special meeting of stockholders or from taking action by written consent and provisions that set forth advance notice procedures for stockholders’ nominations of directors and proposals of topics for consideration at meetings of stockholders. Our certificate of incorporation also provides that Section 203 of the DGCL, which relates to business combinations with interested stockholders, applies to us. These provisions may delay, prevent or deter a merger, or other transaction that might otherwise result in our stockholders receiving a premium over the market price for their common stock. In addition, these provisions may cause our common stock to trade at a market price lower than it might absent such provisions.
		

		
			Structure of Board of Directors
		

		
			Our certificate of incorporation provides for the board to be divided into three classes, as nearly equal in number as possible, serving staggered terms. About one-third of the board will be elected annually, and each member will serve a three-year term. The provision for a classified board could prevent a party who acquires control of a majority of the outstanding voting shares from obtaining control of the board until the second annual stockholders meeting following the date the acquirer obtains the controlling share interest. The classified board provision is designed to have the effect of discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control of Lumber Liquidators and to increase the likelihood that incumbent directors will retain their positions. Under the DGCL, directors of a corporation with a classified board may only be removed for cause unless the certificate of incorporation provides otherwise. 

		 

		

			 

		

Our certificate of incorporation does not provide that our stockholders can remove the directors without cause. Directors are elected by plurality vote, provided that any director so elected who does not receive an affirmative vote of the majority of the votes cast by shares entitled to vote in the election shall submit his or her resignation and the board of directors will decide whether to accept or reject the resignation.
		

		
			Stockholder Action and Special Meetings of Stockholders
		

		
			Our certificate of incorporation provides that stockholder action can be taken only at an annual or special meeting of stockholders and cannot be taken by written consent in lieu of a meeting. Our bylaws provide that, except as otherwise required by law, annual or special meetings of the stockholders can only be called pursuant to a resolution adopted by a majority of the total number of directors then in office or by the chairperson of the board or directors.  Stockholders are not permitted to call a general meeting or to require the board of directors to call a general meeting. 
		

		
			Stockholder Proposals and Director Nominations
		

		
			The bylaws establish an advance notice procedure for stockholder proposals to be brought before a general meeting of stockholders, including proposed nominations of persons for election to the board of directors. Stockholders at a general meeting may only consider proposals or nominations specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder who was a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has given timely written notice, in proper form, of the stockholder’s intention to bring that business before the meeting. Although neither the certificate of incorporation nor the bylaws gives the board of directors the power to approve or disapprove stockholder nominations of candidates or proposals about other business to be conducted at a general meeting, the certificate of incorporation and the bylaws may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed or may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect its own slate of directors or otherwise attempting to obtain control of Lumber Liquidators. 
		

		
			Business Combinations
		

		
			Our certificate of incorporation provides that the provisions of Section 203 of the DGCL, which relate to business combinations with interested stockholders, will apply to Lumber Liquidators. Section 203 of the DGCL generally prohibits “business combinations”, including mergers, sales and leases of assets, issuances of securities and similar transactions by a corporation or a subsidiary with an interested stockholder who beneficially owns 15% or more of a corporation’s voting stock, within three years after the person or entity becomes an interested stockholder, unless: (i) the board of directors of the target corporation has approved, before the acquisition time, either the business combination or the transaction that resulted in the person becoming an interested stockholder, (ii) upon consummation of the transaction that resulted in the person becoming an interested stockholder, the person owns at least 85% of the corporation’s voting stock (excluding shares owned by directors who are officers and shares owned by employee stock plans in which participants do not have the right to determine confidentially whether shares will be tendered in a tender or exchange offer) or (iii) after the person or entity becomes an interested stockholder, the business combination is approved by the board of directors and authorized at a meeting of stockholders by the affirmative vote of at least 66-2/3% of the outstanding voting stock now owned by the interested stockholder. 
		

		
			Amendments to Bylaws
		

		
			Our board of directors will be permitted to alter certain provisions of our bylaws without obtaining stockholder approval. 
		

		
			Limitation of Liability and Indemnification of Officers and Directors 
		

		
			Under Section 145 of the DGCL, a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal,  administrative or investigative (other than an action by or in the right of such corporation), by reason of the fact that the person is or was an officer, director, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding if the person acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person’s conduct was unlawful.  In actions brought by or in the right of the corporation, a corporation may indemnify such person against expenses (including attorneys' fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper.  To the extent that such person has been successful on the merits or otherwise in defense of any such action, suit or proceeding referred to above, or in defense of any claim, issue or matter therein, he or she is entitled to indemnification for expenses (including attorneys' fees) actually and reasonably incurred by such person in connection therewith. The indemnification and advancement of expenses provided for or granted pursuant to Section 145 of the DGCL is not exclusive of any other rights of indemnification or advancement of expenses to which those seeking indemnification or advancement may be entitled. Further, a corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of such person's status as such, whether or not the corporation would have the power to indemnify such person against such liability under Section 145 of the DGCL.
		

		
			

		 

		

			 

		

		

		
			Section 102(b)(7) of the DGCL enables a corporation in its certificate of incorporation to eliminate or limit monetary damages for breach of fiduciary duty as a director, provided that such provision shall not eliminate or limit the liability of a director: (i) for any breach of the director's duty of loyalty to the corporation or its stockholders; (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) pursuant to Section 174 of the DGCL (providing for liability for directors for unlawful payment of dividends or unlawful stock purchases or redemptions); or (iv) for any transaction from which the director derived an improper personal benefit. Advancement or reimbursement of expenses prior to a final disposition requires a written affirmation that the foregoing criteria were met and an undertaking to repay any advances if it is ultimately determined that the criteria were not met.
		

		
			Our certificate of incorporation provides that a director will not be personally liable for monetary damages for breach of fiduciary duty as a director, except liability for (i) any breach of the director’s duty of loyalty to us or our stockholders; (ii) acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law; (iii) unlawful payments of dividends or unlawful stock repurchases or redemptions; or (iv) any transaction from which the director derived an improper personal benefit.
		

		
			Further, our certificate of incorporation and bylaws provide, among other things, that each person who was or is made a party or is threatened to be made a party to or is involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she, or a person of whom he or she is the legal representative, is or was a director or officer of us or is or was serving at our request as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust or other enterprise, including service with respect to employee benefit plans, whether the basis of such proceeding is alleged action in an official capacity as a director, officer, employee or agent or in any other capacity while serving as a director, officer, employee or agent, shall be indemnified and held harmless by us to the fullest extent authorized by the DGCL, against all expense, liability and loss (including attorneys’ fees, judgments, liens, amounts paid or to be paid in settlement and excise taxes or penalties arising under the Employee Retirement Income Security Act of 1974) reasonably incurred or suffered by such person in connection therewith and such indemnification shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of his or her heirs, executors and administrators; provided, however, that we will indemnify any such person seeking indemnification in connection with a proceeding (or part thereof) initiated by such person only if such proceeding (or part thereof) was authorized by the board of directors.
		

		
			Our certificate of incorporation and bylaws provide that the right to indemnification includes the right to be paid by us the expenses (including attorneys’ fees) incurred in defending such proceeding in advance of its final disposition; provided, however, that if the DGCL requires, the payment of such expenses incurred by a director or officer in his or her capacity as such in advance of the final disposition of a proceeding will be made only upon delivery to us of an undertaking, by or on behalf of such director or officer, to repay all amounts so advanced if it shall ultimately be determined by final judicial  decision from which there is no further right to appeal that such director or officer is not entitled to be indemnified under the certificate of incorporation, bylaws or otherwise; and provided, further, that such advancement of expenses incurred by any person other than a director or officer shall be made only upon the delivery of an undertaking to the foregoing effect and may be subject to such other conditions as the board of directors may deem advisable. 
		

		
			Our certificate of incorporation and bylaws also permit us to purchase and maintain insurance to protect the company and any of our directors, officers, employees or agents or another corporation, partnership, joint venture, trust, employee benefit plan, or other enterprise against any such expense, liability or loss, whether or not we would have the power to indemnify such person against such expense, liability or loss under the DGCL.
		

		
			We have in the past and may in the future enter into agreements to indemnify our directors, executive officers and other employees as determined by the board of directors. These agreements will provide for the indemnification of directors and officers to the fullest extent permitted by Delaware law, whether or not expressly provided for in our bylaws, and govern the process by which claims for indemnification are considered.
		

		
			Transfer Agent and Registrar 
		

		
			The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. 
		

		
			Listing 
		

		
			Our common stock is listed on the New York Stock Exchange under the symbol “LL.”

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00305-of-00352.parquet"}]]